Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abdominal distention
acquired immunodeficiency syndrome
adverse drug reaction
agranulocytosis
amyloid angiopathy, cerebral
anemia
anemia, hemolytic
animal exposure
anorexia
anticardiolipin antibodies
anticonvulsants
anticonvulsants, untoward effects of
antiphospholipid antibodies
antiphospholipid antibody syndrome
Asians
autoantibodies
autoimmune disease
behavioral disorder
belligerent
blacks
blood dyscrasias, neurologic findings with
body temperature
brain natriuretic peptide
BUN, elevated
cancer associated hypercoagulation
cancer, cerebrovascular accident complicating patients with
carbamazepine
carcinoma
carcinoma of lung
carotid artery disease
CAT scan
CAT scan, abnormal
CAT scan, chest
CD4 counts
central nervous system, infection of
cerebral embolism
cerebral embolism, cardiac origin
cerebral embolism, carotid origin
cerebral venous infarction
cerebral venous thrombosis
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, bilateral
cerebrovascular accident, cryptogenic
cerebrovascular accident, etiology
cerebrovascular accident, multiple
cerebrovascular accident, non atherosclerotic cause of
cerebrovascular accident, pathophysiology
cerebrovascular accident, three territory involvement
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, volume
cerebrovascular accident, women
cerebrovascular accident, young adult
chest x-ray, abnormal
chorionic gonadotropin
Clinical Pathologic Conference(C.P.C.)
clot histology
clot retrieval
coagulopathy
coma
comorbidities
complications
confusion
Coombs test, positive
cortical blindness
cortical vein thrombosis
cough
coumarin
C-reactive protein, elevated
D-dimer
delay in diagnosis
diet
dilantin
dilantin, toxicity
disorientation
disseminated intravascular coagulation(DIC)
dural sinus thrombosis
ecchymoses
echocardiogram
echocardiogram, transesophageal
embolism
encephalopathy
endocarditis
endocarditis, marantic
enzyme, defect
epidemiology of neurology
false positive VDRL
fever
fibrin split products
fibrinolytic agents
fibrinolytic agents, complications
gray hair
hamster
headache
headache, severe
heart murmur
hematopoietic tissue, extramedullary
hematuria, microscopic
hemiplegia
hemorrhagic diathesis
heralding manifestation
Hispanics
human immunodeficiency virus type 1
hypercoagulable state
hypergammaglobulinemia
hyperhomocysteinemia
immunosuppression
immunosuppressive agents
intellectual deficit
intracerebral hemorrhage
lactic dehydrogenase(LDH)
leuko-araiosis
leukocytosis
leukopenia
livedo reticularis
liver function enzymes
liver transplantation
lupus anticoagulant
lymphocytic choriomeningitis
lymphoma
lymphopenia
malaise
mental status, abnormal
microangiopathic hemolytic anemia
microhemorrhage, intracerebral
middle cerebral artery, occlusion of
mimics
misdiagnosis
mitral valve lesion
mitral valve vegetation
monoclonal gammopathy
mortality
MRI
MRI, abnormal
MRI, gradient echo, vessel sign
MRI, gradient-echo
MRI, susceptibility weighted
multiple organ infarct
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neuropathy
neutropenia
night sweats
opportunistic infection
organ donor
organ transplantation
ovarian hyperstimulation syndrome
ovary, enlarged
pain, abdominal
partial thromboplastin time, prolonged
pathology
petechiae
polyclonal gammopathy
postpartum
pregnancy, neurologic complications in
prethrombotic state
prevention of neurologic disorders
primary thrombocythemia
pulmonary embolism
pyruvate-kinase deficiency anemia
rash
red clot
renal failure
renal infarct
renal transplantation
review article
rheumatoid arthritis factor(R.A.factor)
risk factors
rodents
seizure
sicca syndrome
Sjogren's syndrome
small vessel disease
sodium valproate
sodium valproate, toxicity
spinal cord, compression of
splenic infarcts
splenomegaly
splinter hemorrhages
systemic illness
systemic lupus erythematosus
thrombocytopenia
thrombocytosis
thrombolysis, mechanical
thrombophlebitis
thrombotic thrombocytopenia purpura
tissue plasminogen activator, intravenous
transient ischemic attack
transient ischemic attack, treatment of
treatment of neurologic disorder
troponin T
urinary casts
vasculopathy
vegetarianism
venous thrombosis, non-cerebral
viral infection
viral infection, CNS
weakness
weight loss
white clot
white matter disease
whites
Showing articles 1150 to 1200 of 2619 << Previous Next >>

Approval of the MERCI Clot Retriever-A Critical View
Stroke 36:400-403, Becker, K.J.., & Brott, T.G., 2005

Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005

Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005

Intraocular Haemorrhage after Thrombolysis
Lancet 365:330, Kaba, R.A., et al, 2005

Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
JAMA 293:427-436, The CREATE Trial Group Investigators, 2005

Early Surgery Versus Initial Conservative Treatment in Patients with Spontaneous Supratentorial Intracerebral Haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a Ran
Lancet 365:387-397, 361, Mendelow, A.D., et al, 2005

Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005

The Pathophysiology of Watershed Infarction in Internal Carotid Artery Disease
Stroke 36:567-577, Momjian-Mayor, I. & Baron, J-C., 2005

Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 352: 777-785, 828, Mayer, S.A., et al, 2005

Prioritizing interventions to Improve Rates of Thrombolysis for Ischemic Stroke
Neurol 64:654-659, California Acute Stroke Pilot Registry (CASPR) Inv, 2005

Giant Tumefactive Perivascular Spaces
AJNR 26:298-305, Salzman, K.L., et al, 2005

Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005

Delayed Resolution of White Matter Changes Following Therapy of B Burgdorferi Encephalitis
Neurol 64 :758-759, Steinbach, J.P., et al, 2005

Spinal Cord Transient Ischemic Attacks: A Possible Role for Abciximab
Neurol 64: 761-762, Hussain, M.S., et al, 2005

Unusual Variants of Alexander's Disease
Ann Neurol 57:327-338, van der Knaap,M.S., et al, 2005

Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005

Sonothrombolysis in Acute Ischemic Stroke for Patients Ineligible for rt-PA
Neurol 64:1052-1054, Eggers,J., et al, 2005

Prospective Reliability of the Stroke Doc Wireless/Site Independent Telemedicine System
Neurol 64:1058-1060, Meyer,B.C., et al, 2005

Clinicopath Conf, Human Granulocytic Ehrlichiosis
NEJM 352:1358-1364, Case 10-2005, 2005

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005

Leukoencephalopathy with Ataxia, Hypodontia, and Hypomyelination
Neurol 64:1461-1464, Wolf,N.I.,et al, 2005

Reversal of Warfarin-Induced Anticoagulation with Factor VIIa Prior to rt-PA in Acute Stroke
Neurol 64:1480-1481, Talkad,A.,et al, 2005

Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005

Mechanical Thrombectomy for Acute Stroke
AJNR 26:875-879, Versnick,E.J.,et al, 2005

Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005

Dilated Perivascular Spaces: Hallmarks of Mild Traumatic Brain Injury
AJNR 26:719-724,692, Inglese,M.,et al, 2005

Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005

The Genetic Causes of Basal Ganglia Calcification, Dementia, and Bone Cysts
Neurol 64:1502-1507, Klunemann,H.H.,et al, 2005

Atypical PML Leading to a Diagnosis of Common Variable Immunodeficiency
Neurol 64:1661, Snyder,M.D.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

Brain Magnetic Resonance Imaging Findings in Patients with Mitochondrial Cytopathies
Arch Neurol 62:737-742, Barragan-Campos,H.M.,et al, 2005

Prevalence of Leukoencephalopathy in Children Treated for Acute Lymphoblastic Leukemia with High-Dose Methotrexate
AJNR 26:1263-1269, Reddick,W.E.,et al, 2005

Acute Intermittent Porphyria Presenting as a Diffuse Encephalopathy
Ann Neurol 67:581-584, Maramattom,B.V.,et al, 2005

Corpus Callosum Changes Following Shunting for Hydrocephalus: Case Report and Review of the Literature
Clin Neurology and Neurosurgery 107:351-354, Constantinescu,C.S.,et al, 2005

Fatal Toxic Leukoencephalopathy: Clinical, Radiological, and Necropsy Findings in Two Patients
JNNP 76:1014-1016, Ryan,A.,et al, 2005

Utility of an Ultrafast Magnetic Resonance Imaging Protocol in Recent and Semi-Recent Strokes
JNNP 76:1002-1005,905, U-King-Im,J.M.,et al, 2005

Effect of Pravastatin on Cerebral Infarcts and White Matter Lesions
Neurol 64:1807-1809, ten Dam,V.H.,et al, 2005

Leukoencephalopathy From "Chasing the Dragon"
Neurol 64:1755, Halloran,O.,et al, 2005

Ambulatory Blood Pressure and The Brain, A 5-Year Follow-Up
Neurol 64:1846-1852, Goldstein,I.B.,et al, 2005

NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005

Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005

Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005

Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005

Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005

Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke 36:1512-1518, Wojner-Alexandrov,A.,et al, 2005

Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
Stroke 36:1452-1456, Rubiera,M.,et al, 2005

Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke, Results of the MERCI Trial
Stroke 36:1432-1440, Smikth,W.D.,et al, 2005



Showing articles 1150 to 1200 of 2619 << Previous Next >>